Company facts
- Headquarters
- Las Vegas, Nevada
- Most recent report
- 10-Q, filed Sep 14, 2026
- Incorporated
- Nevada
- Filings on record
- 471 filings
- On EDGAR
- CIK 1157075
- Fiscal year ends
- April
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 92
News 8 of 112
- 8-K Leadership change Apr 2, 2026
- 8-K Current report on a material event Dec 5, 2025
- 8-K/A Current report on a material event, amended Nov 18, 2025
- 8-K Leadership change Oct 31, 2025
- 8-K Significant contract Sep 5, 2025
- 8-K Significant contract Aug 18, 2025
- 8-K Shareholder vote results Apr 24, 2025
- 8-K Current report on a material event Feb 26, 2025
Prospectuses and Registrations 8 of 26
- S-3 Shelf registration statement Sep 17, 2025
- S-8 Registration statement for an employee plan Dec 4, 2024
- S-3/A Shelf registration statement, amended Sep 21, 2023
- S-3/A Shelf registration statement, amended Sep 12, 2023
- S-3/A Shelf registration statement, amended Aug 4, 2023
- S-3 Shelf registration statement Jun 9, 2023
- 424B3 Prospectus supplement for an offering Nov 22, 2021
- S-3 Shelf registration statement Nov 8, 2021
Proxies 8 of 19
- DEF 14A Proxy statement for a shareholder vote Mar 9, 2026
- PRE 14A Preliminary proxy statement Feb 27, 2026
- DEF 14A Proxy statement for a shareholder vote Oct 6, 2025
- PRE 14A Preliminary proxy statement Sep 24, 2025
- DEFA14A Extra proxy material Mar 10, 2025
- DEF 14A Proxy statement for a shareholder vote Mar 10, 2025
- DEF 14A Proxy statement for a shareholder vote Mar 27, 2024
- DEF 14A Proxy statement for a shareholder vote Jul 31, 2023
Ownership 8 of 76
- 4/A Insider reported a trade, amended Jul 17, 2026
- 4/A Insider reported a trade, amended Jul 17, 2026
- 4/A Insider reported a trade, amended Jul 17, 2026
- 4/A Insider reported a trade, amended Jul 17, 2026
- 4 Insider reported a trade Apr 2, 2026
- 4 Insider reported a trade Apr 2, 2026
- 4 Insider reported a trade Apr 2, 2026
- 4 Insider reported a trade Apr 2, 2026
Other 8 of 146
- ARS Annual report sent to shareholders Mar 9, 2026
- NT 10-Q Notice that a quarterly report will be late Dec 15, 2025
- EFFECT Notice that a registration became effective Sep 26, 2025
- CORRESP Reply to SEC staff Sep 24, 2025
- UPLOAD Comment letter from SEC staff Sep 23, 2025
- D Sep 4, 2025
- NT 10-K Notice that an annual report will be late Jul 29, 2025
- ARS Annual report sent to shareholders Mar 10, 2025
Everything here comes from PharmaCyte Biotech, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.